High expression of EVI-1 can lead to poor prognosis in breast cancer patients with estrogen receptor negative [24–26], suggesting that transcription factor EVI-1 may play a carcinogenic role by promoting the growth, migration and invasion of breast cancer stem cells. This evidence concerns the gene ESR1 and breast carcinoma.